ORAL PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC COMPOUND

WIPO Patent Application WO/2021/029430

A1

The present invention provides a means that can prevent excessive release of an active ingredient at an initial stage and that is capable of releasing the active ingredient in a sustained manner over a long period of time at a therapeutic effective dose.

JP2019077644	PHARMACEUTICAL COMPOSITION AND METHOD OF PRODUCING PHARMACEUTICAL COMPOSITION
JP2009185417	CELLULOSE NANO-FIBER NONWOVEN SHEET
WO/2013/164122	AQUEOUS DISPERSIONS OF CONTROLLED RELEASE POLYMERS AND SHELLS AND CAPSULES THEREOF

YOSHIMURA MOTOYASU (JP)
FUJII TAKUYA (JP)
KAMADA NAOKI (JP)
TOGASHI RYOHEI (JP)
AONO RYUTA (JP)
WANG XINYU (JP)

PCT/JP2020/030777

February 18, 2021

August 13, 2020

Click for automatic bibliography generation  

OTSUKA PHARMA CO LTD (JP)

A61K47/38; A61K31/496

WO2013054872A1

2013-04-18

JP2014510023A	2014-04-24
JP2008115172A	2008-05-22
CN106667969A	2017-05-17
JP2006316052A	2006-11-24
US3173876A	1965-03-16
US3276586A	1966-10-04
US3541005A	1970-11-17
US3541006A	1970-11-17
US3546142A	1970-12-08
US3133132A	1964-05-12
US3865108A	1975-02-11
US4002173A	1977-01-11
US4207893A	1980-06-17
US2799241A	1957-07-16
US3916899A	1975-11-04
US4088864A	1978-05-09

"Leading Edge Technologies for Oral Delivery of Poorly Soluble Drugs", 30 November 2015, CMC PUBLISHING, JP, ISBN: 978-4-7813-1169-2, article KAWAKAMI, KOHSAKU: "2.2 The status quo of the selection process", pages: 68 - 73, XP009534562
"Control and Assessment of Pharmaceutical Solid Polymorphism", 30 November 2010, CMC PUBLISHING CO., LTD., JP, ISBN: 978-4-7813-0519-6, article KAWAKAMI, KOHSAKU: "1.7 Microscopic pH change due to salt", pages: 98 - 99, XP009534563

SAEGUSA & PARTNERS (JP)

View/Download PDF      PDF Help

Previous Patent: ORAL PHARMACEUTICAL COMPOSITION

Next Patent: BILIARY ATRESIA DIAGNOSIS SUPPORT MANAGEMENT SYSTEM